Golden State Equity Partners Cyma Bay Therapeutics, Inc. Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 54,289 shares of CBAY stock, worth $0. This represents 0.32% of its overall portfolio holdings.
Number of Shares
54,289
Previous 50,000
8.58%
Holding current value
$0
Previous $745,000
72.08%
% of portfolio
0.32%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding CBAY
# of Institutions
12Shares Held
1.88MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iii, LLC Larkspur, CA1.64MShares$015.17% of portfolio
-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Connacht Asset Management LP New York, NY12KShares$01.09% of portfolio
-
Ctc Capital Management, LLC10.7KShares$00.2% of portfolio
-
Pictet Asset Management Sa Geneva 73, V810.6KShares$00.0% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...